Justera Health Ltd C.VTAL

CEO BOARD RE:SCRN

[bohemian62]

@rockfish found this post on another site..................DD for Compel Capital Inc. (ScreenPro) BEFORE they take off. DD Hate being late to the party? I sure do. I love reading all your DD's but they seem to come out after a big spike in SP. Not this time... Enter Compel Capital Inc. (ScreenPro), a company that provides turnkey coronavirus screening solutions to the private sector. ScreenPro's unique access to multiple manufacturers of high quality South Korean test kits, and a strategic partnership with Canvas Labs in Vancouver and Integrated Explorations in Ontario allows them to be a nationwide provider of full-service testing solutions across Canada. In addition to providing test kits, ScreenPro has its own pool of certified nursing professionals, and access to high quality PPE to ensure that its clients are protected in all aspects of their testing needs. They mainly provide testing for the Film and Television Industry, and I can tell you firsthand that it is a careful business. Whenever I get called for a day on a show I have to pass three tests before I'm allowed to work (two on separate days leading up and one the day of). With restrictions lifting the unions are operating at near full capacity to make up for lost time so you can expect a rise in testing for the foreseeable future. They've already bumped their testing capacity from 2,500 (October 2020) to 70,000 tests per month. ScreenPro currently generates $100 revenue per test and they've performed approximately 60,000 tests in January and February and are poised to deliver 40,000 for the month of March. That's a gross revenue of $10,000,000! They're currently valued at $4,030,000 so you can expect to see that number jump on their next ER. As well, they've recently been approved to bid on NHS contracts in the UK. It's estimated that the overall value of the NHS tender for the city of London alone, is over 900 million GBP (equivalent to $1.574 Billion CDN) and illustrates how the country is preparing to screen its citizens for all variants of the virus for the next two years. Even if they don't land the contract, it's impressive because... "The NHS of London is the medical agency for the City of London tasked with ensuring the medical health and safety of all of its 9.4 million citizens. To become a qualified supplier, the entity and its product offering have to be stringently reviewed and approved by the National Health Service (NHS) prior to bidding." https://finance.yahoo.com/news/screenpro-approved-bid-nhs-london-080000187.html So they passed the test! And yet they're still grossly undervalued. Granted, they're a recent IPO but they already had their post IPO freefall and have shown strong resistance around the $0.075 mark, currently trading around $0.10 per share. I strongly believe this is one of those situations where you'll wish you jumped in while it's trading under a buck. This isn't a pump, I just want to give back to the community before the SP jumps and everyone's afraid they're too late to the party. If they do manage to get any NHS contracts you'll be glad you're already in. The only thing I can think of for a bear case is that this is a penny stock, and they all come with some risk, but this company has sedar filings going back to 1998 so I suspect they're not going anywhere anytime soon. I'm pretty new to this, so I'd really appreciate any insight you can share that might help me bolster both cases. I'd like to get better at this someday... Position 20,000 @ 0.10 Edit: CEO recently bought 550k shares at $0.085